---
layout: minimal-medicine
title: Urofollitropin (FSH)
---

# Urofollitropin (FSH)
### Generic Name
Urofollitropin (FSH)

### Usage
Urofollitropin, a form of follicle-stimulating hormone (FSH), is primarily used in women undergoing assisted reproductive technologies (ART) to stimulate the development of multiple follicles in the ovaries.  This is crucial for procedures like in-vitro fertilization (IVF).  A secondary use is in ovulation induction for women who have received prior pituitary suppression therapy. In men, it may be used to aid in spermatogenesis,  the process of sperm production, though this application is less common.


### Dosage
Dosage varies significantly depending on the indication (ovulation induction, ART, or spermatogenesis) and individual response.  It's crucial to follow a healthcare professional's guidance closely as dosages are highly individualized.

**Ovulation Induction (IM/SubQ):** Typically begins with 150 IU daily for 5 days.  The dose is adjusted every 2 days, if needed, based on follicle growth monitored via ultrasound and estradiol levels. Maximum daily dose is 450 IU, with treatment lasting up to 12 days.


**Assisted Reproductive Technology (ART) in Females (SubQ):** Usually starts at 225 IU daily beginning on day 2 or 3 of the menstrual cycle if the patient has undergone GnRH agonist pituitary suppression.  The dose can be adjusted every two days based on follicle growth and estradiol levels, aiming for adequate follicular development before administering hCG (human chorionic gonadotropin). The maximum daily dose is 450 IU, and treatment typically does not exceed 12 days.  Urofollitropin may be used in conjunction with menotropins; if combined, the total daily dose should not exceed 225 IU.

**Spermatogenesis (SubQ):**  A patient will initially undergo pretreatment with hCG until serum testosterone levels are within the normal range. This is followed by 150 IU of Urofollitropin three times weekly, along with continued hCG administration three times per week. The dose may be adjusted as needed and should not exceed 300 IU three times weekly.  Treatment can last up to 18 months.


**Pediatric Dosage:**  The safety and effectiveness of Urofollitropin in children have not been established.

**Dosage Adjustments for Renal or Hepatic Impairment:**  The manufacturer's labeling does not provide specific dosage adjustments for patients with renal or hepatic impairment.  Consult with a healthcare provider for appropriate management.



### Side Effects
Common side effects (frequency varies):

* **Ovarian Hyperstimulation Syndrome (OHSS):** This is a serious complication and can range from mild to severe; characterized by ovarian enlargement and potentially life-threatening complications.
* Headache
* Abdominal Cramps
* Ovarian Enlargement
* Nausea and Vomiting
* Injection site reactions
* Breast tenderness
* Depression
* Emotional lability
* Weight gain
* Skin rash


Less common but potentially serious side effects:

*  Pulmonary and vascular complications
* Ovarian torsion (twisting of the ovary)
* Multiple births
* Ectopic pregnancy (pregnancy outside the uterus)
* Spontaneous abortion
* Thromboembolic events


If any adverse effects occur, it is crucial to seek medical advice immediately.


### How it Works
Urofollitropin is a purified form of FSH extracted from the urine of postmenopausal women. FSH plays a vital role in stimulating the growth and maturation of ovarian follicles in women and is also involved in spermatogenesis in men.  By mimicking the natural action of FSH, Urofollitropin promotes follicle development, leading to ovulation in women and sperm production in men. This effect is crucial for assisted reproductive techniques and in certain cases of ovulation induction.


### Precautions
* **Contraindications:** Urofollitropin is contraindicated in individuals with hypersensitivity to the drug, primary ovarian failure, uncontrolled endocrinopathies (thyroid, adrenal, or pituitary disorders), sex hormone-dependent tumors, pituitary or hypothalamic tumors, unexplained uterine bleeding, ovarian cysts or enlargement (unrelated to PCOS), and pregnancy.
* **Warnings:**  There is an increased risk of OHSS, multiple pregnancies, and birth defects.  Women with personal or family history of thromboembolic events should use caution.  Close monitoring is necessary during treatment.
* **Drug Interactions:**  No significant drug interactions are specifically mentioned in the manufacturer's information, but potential interactions with other medications affecting hormone levels or coagulation should be considered. Discuss all medications with your doctor.
* **Pregnancy and Lactation:** Urofollitropin is classified as Pregnancy Category X and is contraindicated during pregnancy. It's also excreted in breast milk; a decision on whether to discontinue breastfeeding or the medication should be made in consultation with a healthcare professional.


### FAQs

* **Q: How is Urofollitropin administered?** A:  It can be administered intramuscularly (IM) or subcutaneously (SubQ), depending on the specific instructions of your doctor.

* **Q: How long does treatment last?** A:  The duration of treatment varies significantly based on the medical condition and individual response, ranging from a few days to many months. Your doctor will determine the appropriate treatment duration.

* **Q: What are the long-term effects of Urofollitropin?** A: Long-term effects are generally associated with the specific condition being treated and potential complications, such as OHSS.  A doctor can explain any potential long-term implications for your specific situation.

* **Q: How should Urofollitropin be stored?** A: Always store medication according to the manufacturer's instructions on the packaging.

* **Q: Can I stop taking Urofollitropin if I experience side effects?** A: No, do not stop taking the medication without consulting your healthcare provider.  They can assess the side effects and adjust the treatment plan as needed.  Stopping abruptly could have adverse consequences.


**Disclaimer:** This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized guidance based on your individual medical history and current condition.
